Lymphoma: all 5,624 studies
Page 24 of 57. Open to participants first (824), then studies with results posted, then the rest; newest registration first within each.
- Clinical Study of Autologous Stem Cell Transplantation + Anti-CD19 CAR T Cells for B-cell LymphomaStatus unknownNCT05755828Phase 2
- SUper-Resolution Ultrasound Imaging of Erythrocytes (SURE) in Normal and Malignant Lymph NodesCompletedNCT05754814
- Phase I/IIa Study of BR1733 in Subjects With Advanced CancersActive, not recruitingNCT05749549Phase 1/2
- HEM-iSMART-A: Decitabine / Venetoclax and Navitoclax in Pediatric Patients With Relapsed or Refractory Hematological MalignanciesWithdrawnNCT05740449Phase 1/2
- First-in-human Dose Escalation and Expansion Study With the SIRPα-directed Monoclonal Antibody BYON4228Active, not recruitingNCT05737628Phase 1
- Expanded Access Program for EpcoritamabApproved for marketingNCT05733650
- A Study of MS-553 in Patients With Relapsed or Refractory B-cell LymphomaTerminatedNCT05720052Phase 1/2
- A Study of Tazemetostat in Combination With HMPL-689 in Patients With Relapsed/Refractory LymphomaCompletedNCT05713110Phase 2
- A Trial Comparing Chemotherapy Versus Novel Immune Checkpoint Inhibitor (Pembrolizumab) Plus Chemotherapy in Treating Relapsed/Refractory Classical Hodgkin LymphomaWithdrawnNCT05711628Phase 3
- Study of VP301 in Patients With Multiple Myeloma, Lymphoma, or Solid TumorsTerminatedNCT05698888Phase 1
- A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular LymphomaActive, not recruitingNCT05683171Phase 1/2
- Penpulimab in Maintenance Therapy in LymphomaStatus unknownNCT05680038
- The Study of Anti-CD19 CAR NK Cells in the Treatment of Relapsed/Refractory Diffuse Large B Cell LymphomaStatus unknownNCT05673447Early Phase 1
- Siltuximab for the Prevention of CAR T Cell Related Cytokine Release Syndrome in Patients With CD19 Positive Non-Hodgkin LymphomaCompletedNCT05665725Phase 1
- Multicentric and Retrospective Analysis of Adolescent Young Adult (AYA) Hodgkins' Lymphoma PatientsStatus unknownNCT05663983
- Multicenter Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab, Bendamustine, Gemcitabine, Vinorelbine (Nivo-BeGEV) in Patients With Relapsed/Refractory Hodgkin LymphomaStatus unknownNCT05660993Phase 2
- A Study to Evaluate the Pharmacokinetics and Safety of Loncastuximab Tesirine in Participants With Relapsed or Refractory Diffuse Large B-cell Lymphoma or High-grade B-cell Lymphoma With Hepatic Impairment (LOTIS-10)TerminatedNCT05660395Phase 1
- Human CD19-CD22 Targeted T Cells Injection for Refractory/Relapsed Central Nervous System Leukemia/Lymphoma PatientsActive, not recruitingNCT05651178Early Phase 1
- Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.TerminatedNCT05645744
- Phase I Dose Escalation and Pharmacokinetics Clinical Trial of Mitoxantrone Hydrochloride Liposome in Children With Relapsed and Refractory Lymphoma and Solid TumorsActive, not recruitingNCT05620862Phase 1
- CD19 CAR T-cell Target Relapsed/Refractory Acute B Cell Leukemia/LymphomaWithdrawnNCT05613348Phase 1/2
- Study of BN301, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell MalignanciesTerminatedNCT05611853Phase 1/2
- A Phase I Study to Investigate the Safety, Tolerability and PK of HLX60 (Anti-GARP Monoclonal Antibody) in Subjects With Solid Tumors or LymphomaActive, not recruitingNCT05606380Phase 1
- Zandelisib + Tazemetostat in R/R Follicular LymphomaWithdrawnNCT05604417Phase 1/2
- Sensitivity and Specificity of Cytokines in the Diagnosis of Lymphoma-associated HLHCompletedNCT05600959
- 13C Pyruvate DNP MR Spectroscopy for Lymphoma Treatment Response AssessmentStatus unknownNCT05600361Not applicable
- A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic MalignanciesActive, not recruitingNCT05589896Phase 1/2
- A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell LymphomaStatus unknownNCT05569057Phase 1
- A Study to Learn About the Study Medicine (Called Maplirpacept (PF-07901801)) in Japanese With Hematologic MalignanciesCompletedNCT05567887Phase 1
- Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or LymphomasActive, not recruitingNCT05565417Phase 1/2
- Chimeric Antigen Receptor T-Cell (CAR-T) Cells in Patients With R/R T-LBLStatus unknownNCT05554575Phase 1
- Low-dose Radiotherapy in iNHLStatus unknownNCT05543070Phase 2
- Comparison of Clinical Outcomes Among Patients Treated With TisagenlecleucelCompletedNCT05541328
- A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell TransplantActive, not recruitingNCT05540340Phase 1
- Multidimensional Assessment of Quality of Life, Social and Professional Life and Care Utilization in Patients With Diffuse Large Cell B-cell Lymphoma Treated With CAR-T CellsStatus unknownNCT05532761
- Signatures of Response and Resistance to Mosunetuzomab in Follicular Lymphomas (FL)CompletedNCT05529524
- A Phase II Study of Rituximab, Chidamide, Zanubrutinib-induced and CHOP TherapyStatus unknownNCT05527912Phase 2
- A Phase I/II Study of Mitoxantrone Liposome Combined With Chidamide in Relapsed/Refractory Peripheral T-cell LymphomaStatus unknownNCT05527275Phase 1/2
- A Study to Investigate the Safety, Tolerability, PK, PD, and Efficacy of ONO-7018 in Patients With R/R NHL or CLLTerminatedNCT05515406Phase 1
- Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With HemoblastosisActive, not recruitingNCT05515029Phase 3
- Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid MalignanciesWithdrawnNCT05513612Phase 1
- Plerixafor for Poorly Mobilized LymphomaStatus unknownNCT05510544Phase 4
- The SOAR Study: a Study of Geriatric Assessment and Exercise for Older Adults and Their Support PersonActive, not recruitingNCT05509751Not applicable
- A Study of People With CD30 Positive Lymphoma in ChinaCompletedNCT05506774
- A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell LymphomaActive, not recruitingNCT05495464Early Phase 1
- A Single-arm, Multicenter, Prospective Clinical Study of Mitoxantrone Liposome Combined With Chidamide and Azacitidine in the Treatment of Relapsed and Refractory Peripheral T-cell LymphomaStatus unknownNCT05495100Phase 2
- Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCTActive, not recruitingNCT05493800Phase 2
- Enhancing Effect on Tumour Apoptosis With the Use of Pentoxifylline in Patients With Hodgkin LymphomaStatus unknownNCT05490953Phase 4
- Donor-Derived CD5 CAR T (CT125B) Cells for Relapsed or Refractory T- Cell Acute Lymphoblastic Leukemia/LymphomaWithdrawnNCT05487495Phase 1
- Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaActive, not recruitingNCT05479994Phase 2
- Study of Let-7a and miRNA-124 in Cases of Non-Hodgkin's Lymphoma and Acute LeukemiaStatus unknownNCT05477667Not applicable
- Study of Efficacy of BZ019 in Large B-cell LymphomaStatus unknownNCT05472610Phase 2
- Tazemetostat for the Treatment of Relapsed/Refractory Follicular LymphomaCompletedNCT05467943Phase 2
- Feasibility of Combined Genomics/Transcriptomics for Patients With LymphomaActive, not recruitingNCT05464823Not applicable
- Tislelizumab Combined with Mitoxantrone Hydrochloride Liposome in Extranodal Natural Killer/T Cell LymphomaActive, not recruitingNCT05464433Phase 1/2
- Safety, Tolerability and Preliminary Efficacy of IBI363 in Subjects With Advanced Solid Tumors or LymphomaActive, not recruitingNCT05460767Phase 1
- Information Support Using an Online Learning Platform for Malaysian Pediatric Leukemia and Lymphoma ParentsCompletedNCT05455268Not applicable
- Atrial Fibrillation Monitoring on Patients With Lymphoma After ChemotherapyStatus unknownNCT05454878
- A Clinical Study of 6MW3211 Injection in the Treatment of Relapsed/Refractory LymphomaStatus unknownNCT05446688Phase 2
- The Effect of Decision Support System on Symptom Self-Management in Non-Hodgkin Lymphoma PatientsCompletedNCT05443165Not applicable
- A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell LymphomaWithdrawnNCT05431179Phase 3
- Ibrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle Cell Lymphoma Patients Who Aged ≤65 YearsStatus unknownNCT05429918
- Mosunetuzumab and Polatuzumab Vedotin for Untreated Follicular LymphomaActive, not recruitingNCT05410418Phase 2
- Nutritional Supplement Based on Myo-inositol-D-chiro-inositoln in Long-term Survivors of LymphomaCompletedNCT05410314
- Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular LymphomaActive, not recruitingNCT05409066Phase 3
- A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007)Active, not recruitingNCT05406401Phase 2
- Ibrutinib Combined With Bendamustine and Rituximab in Newly Diagnosed Mantle Cell Lymphoma Patients Who Aged > 65 YearsStatus unknownNCT05406154
- To Evaluate the Safety and Efficacy of TQB2618 Injection Combined With Penpulimab in the Treatment of Patients With Relapsed and Refractory LymphomaStatus unknownNCT05400876Phase 1/2
- R-MTX-zanbrutinib in Secondary CNS LymphomaStatus unknownNCT05398224Phase 2
- Head-to-head Comparison Between [18F]-FDG PET/CT and PET/MRI in LymphomasStatus unknownNCT05390632
- A Study Evaluating the Safety, Tolerability, Pharmacokinetic and Efficacy of HLX301(TIGIT×PDL1 Bispecific) in Locally Advanced/Metastatic Solid Tumors or LymphomaStatus unknownNCT05390528Phase 1/2
- Screening for Oculocerebral Lymphoma With the Phenotype of NK Cells in Patients With UveitisCompletedNCT05388838Not applicable
- A Prospective Multicenter Phase 2 Study of the Chemotherapy-Free Combination of the Intravenous Phosphatidylinositol-3-Kinase (PI3K) Inhibitor Copanlisib in Combination With Obinutuzumab in Patients With Previously Untreated Follicular Lymphoma (FL) and a High Tumor BurdenActive, not recruitingNCT05387616Phase 2
- Intravenous Injection of Oncolytic Virus Injection (RT-01) in Patients With Relapsed or Refractory T-cell LymphomaStatus unknownNCT05387226Phase 1
- Chemotherapy Induced Peripheral Neuropathy (CIPN) and Lymphoma Longitudinal Follow-up and Prognostic FactorsCompletedNCT05378256Not applicable
- A Phase 1 Study to Evaluate JS019 in Advanced Solid Tumors or LymphomasStatus unknownNCT05374226Phase 1
- Real-world Resource Use and Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma (DLBCL)CompletedNCT05366257
- Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLLTerminatedNCT05360238Phase 1/2
- A Study of ATG-010 in Combination With ATG-008 in Patients With Relapsed/Refractory Diffuse Large B-cell LymphomaTerminatedNCT05354362Phase 1
- Autologous CD30.CAR-T in Combination With Nivolumab in cHL Patients After Failure of Frontline TherapyActive, not recruitingNCT05352828Phase 1
- Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B-NHL After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) TherapyStatus unknownNCT05349266Phase 1
- Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and LymphomaActive, not recruitingNCT05346809Phase 2
- Different Sonographic Modalities and PET-CT in Pediatric LymphomaStatus unknownNCT05343676
- Evaluate the Safety and Effect of ThisCART19A in Patients With AIDS Related B Cell Lymphoma/LympholeukemiaStatus unknownNCT05340829Phase 1
- Real-World Clinical Outcomes in Adult Patients Who Initiate Systemic Treatment for Relapsed/Refractory Diffuse Large B-Cell LymphomaCompletedNCT05338892
- Real-World Clinical Outcomes in Adult Patients Who Initiate Systemic Treatment for Relapsed or Refractory Follicular LymphomaCompletedNCT05338879
- GPL in Patients with Relapsed/refractory Diffuse Large B Cell LymphomaActive, not recruitingNCT05335018Phase 2
- Fatigue Reduction Diet in Lymphoma SurvivorsCompletedNCT05327725Not applicable
- Safety and Efficacy of Lacutamab in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma That Express KIR3DL2CompletedNCT05321147Phase 1
- Camrelizumab Combined With CD30 CAR-T in the Treatment of Relapsed/Refractory CD30+ LymphomaStatus unknownNCT05320081Phase 2
- Study of Mivavotinib (CB-659) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)TerminatedNCT05319028Phase 2
- Targeting CD19/CD20/CD22 Triple-targeted Cell in Patients With Relapsed/Refractory B-cell LymphomaTerminatedNCT05318963Phase 1
- Translational Study of Molecular Classification of Relapsed/Refractory Diffuse Large B-cell LymphomaCompletedNCT05318391
- Efficacy and Safety of BV With Tislelizumab for the Treatment of CD30+ Relapsed/Refractory NK/T-cell LymphomaStatus unknownNCT05316246Phase 2
- GVM±R in Patients With Relapsed or Refractory Aggressive NHLActive, not recruitingNCT05299164Phase 1
- Usefulness of Gadovist-enhanced FLAIR ImagingCompletedNCT05293990Not applicable
- SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma.TerminatedNCT05293912Phase 1
- Study of F527 in Patients With Relapsed or Refractory LymphomaStatus unknownNCT05293028Phase 1
- A Phase 1, Open-label, Multicenter, Dose Escalation Study of IBI363 (PD1-IL2m) in Subjects With Advanced Solid Malignancies or LymphomasActive, not recruitingNCT05290597Phase 1
- Anti-CD7 CAR-T Cell Therapy for Relapse and Refractory CD7 Positive T Cell MalignanciesCompletedNCT05290155Phase 1